Omeros

Omeros Debt

The Debt of Omeros (OMER) as of Nov 17, 2026 is 239.14 M USD. In the previous year, Debt was 207.02 M USD — a change of 15.52% (higher).

Debt

239.14 MUSD

YoY

15.52%

Last updated:

In 2025, Omeros's total debt was 239.14 M USD, a 15.52% change from the 207.02 M USD total debt recorded in the previous year.

The Omeros Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
151.45 M USD
Jan 1, 2019
161.72 M USD
Jan 1, 2020
240.07 M USD
Jan 1, 2021
347.84 M USD
Jan 1, 2022
342.02 M USD
Jan 1, 2023
361.58 M USD
Jan 1, 2024
207.02 M USD
Jan 1, 2025
239.14 M USD
The Omeros Debt history
YEARDebtYoY
239.14 MUSD+15.52%
207.02 MUSD-42.75%
361.58 MUSD+5.72%
342.02 MUSD-1.67%
347.84 MUSD+44.89%
240.07 MUSD+48.45%
161.72 MUSD+6.78%
151.45 MUSD+79.00%
84.61 MUSD+5.71%
80.03 MUSD+59.91%
50.05 MUSD+53.01%
32.71 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Debt Details

Understanding Omeros's Debt Structure

Omeros's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Omeros's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Omeros’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Omeros’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Omeros stock

Debt of Omeros is 239.14 M USD in 2025.

Debt of Omeros changed from 207.02 M USD to 239.14 M USD, representing a 15.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Omeros since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Omeros historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Omeros

All Key Metrics — Omeros